Akesion - One Solution

Of patients who undergo abdominal surgery, over 50% develop adverse adhesions between organs. Adhesions often lead to pain, infertility and, in severe cases, to life-threatening bowel obstruction. A new drug developed by the startup company Akesion removes the main precursor of these adhesions preventing the formation of adhesions as well as risky repeat surgeries that are stressful to patients.

LicenseDefault YouTube License

More videos by this producer

BA Toolbox – A3 Report

In this episode of the BA Toolbox, we explore the A3 report, and it’s use in problem-solving. Show Notes What’s an A3 report? An A3 report has several uses including business proposals and process improvements. However, it’s most commonly used for problem-solving. If you have a tricky problem in y